Key facts
- This page summarizes Nicole D. Perry's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Aug 2021, 16:23.
Nicole D. Perry - 02 Aug 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)
- Reporting relationship
- Vice President - Accounting
- Issuer ticker
- APLS
- Reported as of
- 02 Aug 2021
- Net transaction value
- -$60,230
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2021, 16:23:59 UTC
- Prior SEC filing
- 02 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Watson, attorney-in-fact for Nicole Perry
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nicole D. Perry filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 03 Aug 2021.
Change
- Previous filing in this sequence was filed on 02 Jul 2021.
- Current net transaction value: -$60,230.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Options Exercise
- Transaction value
- $3,760
- Shares
- +1,000
- Change %
- +21%
- Price
- $3.76*
- Shares after
- 5,847
- Date
- 02 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
APLS
transaction
Common Stock
Sale
- Transaction value
- $63,990
- Shares
- -1,000
- Change %
- -17%
- Price
- $63.99
- Shares after
- 4,847
- Date
- 02 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APLS
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -14%
- Price
- $0.000000
- Shares after
- 6,161
- Date
- 02 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $3.76
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This is a scheduled exercise from a 10B5-1 trading plan.
Footnote F2
This option was granted on July 31, 2015 and is fully vested.